Flint Capital

Nokod Raises $8M Seed Round From Seasoned Cybersecurity Investors to Enhance Low-Code/No-Code App Security

Retrieved on: 
Thursday, June 29, 2023
RPA, Meron, Imperva, Medium-altitude long-endurance unmanned aerial vehicle, Synthetic media, Robotic process automation, UiPath, Microsoft, Research, TEL, Risk, Generative, Jeremy Hardy vs. the Israeli Army, Growth, ServiceNow, R, Cryptocurrency, Medical device, Online shopping, Amihai, Flint Capital

TEL AVIV, Israel, June 29, 2023 /PRNewswire/ -- Nokod Security, a company developing security for low-code / no-code custom applications and Robotic Process Automation (RPA), announced its $8 million seed round, which will be used to establish a presence in the United States market, as well as to expand the R&D teams and support novel research of security vulnerabilities in the low-code/no-code domain. Funds were raised from Acrew Capital, Meron Capital and Flint Capital, firms with a successful track record of investing in top companies in the data protection, software verification and cybersecurity sectors like Exabeam, Mitiga, Laminar, Socure, and others.

Key Points: 
  • More so, Generative AI and ChatGPT-like tools, introduced just this past year, are set to hyper-accelerate low-code / no-code development.
  • Although these platforms provide businesses fast application development with minimal complex coding using third-party toolkits, they are not covered by the application security stack.
  • As a result, the applications and automations create a new attack surface as well as introduce the risk of compliance violations.
  • Our product ensures 100% secure citizen development within enterprises,"— notes Yair Finzi, co-founder and СЕО of Nokod Security.

ODAIA Raises $25 Million in Series B Funding to Advance Its AI-Driven Commercial Insights Software for Pharma

Retrieved on: 
Monday, May 1, 2023
Vaccine, Software as a service, Therapy, Workflow, Marketing, BDC, Flint Capital, HCP, Partner, Patient, ARR, AI, Principal, Health, Woman, Automation, Pharmaceutical industry, Sales, Risk management

Emily Melton, Managing Partner of Threshold Ventures and Charles Conn, co-founder and Partner of Monograph Ventures, will join ODAIA’s board.

Key Points: 
  • Emily Melton, Managing Partner of Threshold Ventures and Charles Conn, co-founder and Partner of Monograph Ventures, will join ODAIA’s board.
  • The AI models then analyze data within hours to deliver actionable insights to reps, their managers and marketers.
  • No other platform puts so much information in front of pharma commercial teams so they can make robust data-driven decisions with near-real-time data and insights.
  • Through its impressive predictive technology, ODAIA is unlocking smarter ways for leading life science companies to engage customers and lead to better patient care.